| Title | Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity? |
| Publication Type | Journal Article |
| Year of Publication | 2021 |
| Authors | Crosson, FJ, Covinsky, K, Redberg, RF |
| Journal | JAMA Intern Med |
| Volume | 181 |
| Issue | 10 |
| Pagination | 1278-1280 |
| Date Published | 2021 Oct 01 |
| ISSN | 2168-6114 |
| Keywords | Alzheimer Disease, Amyloid beta-Peptides, Antibodies, Monoclonal, Humanized, Cost-Benefit Analysis, Device Approval, Direct-to-Consumer Advertising, Drug and Narcotic Control, Drug Costs, Humans, Medicare, Nootropic Agents, United States, United States Food and Drug Administration |
| DOI | 10.1001/jamainternmed.2021.4610 |
| Alternate Journal | JAMA Intern Med |
| PubMed ID | 34254992 |
